(Q45183634)

English

Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications

scientific article published in February 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

author name string

Beelen DW

1

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Trenschel R

2

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Casper J

3

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Freund M

4

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Hilger RA

5

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Scheulen ME

6

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Basara N

7

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Fauser AA

8

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Hertenstein B

9

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Mylius HA

10

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Baumgart J

11

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Pichlmeier U

12

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Hahn JR

13

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Holler E

14

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

language of work or name

0 references

publication date

1 February 2005

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

233-241

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704784

21 January 2018

Towards a myeloablative regimen with clinical potential: I. Treosulfan conditioning and bone marrow transplantation allow induction of donor-specific tolerance for skin grafts across full MHC barriers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704784

21 January 2018

Nonmyeloablative conditioning is sufficient to allow engraftment of EGFP-expressing bone marrow and subsequent acceptance of EGFP-transgenic skin grafts in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704784

21 January 2018

Toward a myeloablative regimen with clinical potential: II. Treosulfan induces specific skin graft tolerance across haploidentical MHC barriers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704784

21 January 2018

Treosulfan is an effective inducer of cell death in myeloma cell lines and primary myeloma cells from patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704784

21 January 2018

Treosulfan-induced apoptosis in acute myeloid leukemia cells is accompanied by translocation of protein kinase C delta and enhanced by bryostatin-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704784

21 January 2018

Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704784

21 January 2018

Antileukaemic activity of treosulfan in xenografted human acute lymphoblastic leukaemias (ALL).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704784

21 January 2018

Action of treosulfan in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704784

21 January 2018

Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704784

21 January 2018

Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704784

21 January 2018

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704784

21 January 2018

Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704784

21 January 2018

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704784

21 January 2018

The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704784

21 January 2018

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704784

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704784

7 January 2021

based on heuristic

inferred from DOI database lookup

Regimen-related toxicity in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704784

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan/cyclophosphamide vs total body irradiation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704784

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704784

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Dimensions Publication ID

0 references

release_jn7s4qln3fbbfgs3s64jp6wgde

1 reference

https://api.fatcat.wiki/v0/release/jn7s4qln3fbbfgs3s64jp6wgde

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45183634&oldid=2207136359"